RxDoctor Payments DataLook up a doctor →

Christian Stone, MD

Gastroenterology · Las Vegas, NVNPI 1750308284

Payments from drug & device makers

$3,678,312in general payments, 2019–2025

Across 2,106 payments — averaging $1746.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1.6M
  • Takeda Pharmaceuticals U.S.A., Inc.$329K
  • Eli Lilly$268K
  • Sanofi$249K
  • Janssen Research & Development, LLC$199K
  • E.r. Squibb & Sons, L.L.C.$189K
  • plus $812K from 40 others
$49,595in research payments, 2019–2025

Across 5 payments — averaging $9919.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$38K
  • Eli Lilly$11K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)858$1,632,275
Takeda Pharmaceuticals U.S.A., Inc.189$328,763
Eli Lilly17$268,253
Sanofi26$248,874
Janssen Research & Development, LLC77$198,778
E.r. Squibb & Sons, L.L.C.156$189,057
Pfizer(2 entities)143$166,621
Teva Pharmaceuticals USA, Inc.40$132,699
Janssen Scientific Affairs, LLC97$124,273
Gilead36$111,400
Lilly USA, LLC95$77,307
Johnson & Johnson(2 entities)128$68,420
Amgen8$65,847
Medtronic(2 entities)37$24,734
Bristol Myers Squibb39$13,926
Genentech, Inc.1$9,000
Merck10$3,822
Celltrion USA Inc.11$3,499
Redhill Biopharma Inc.16$3,388
Sanofi US Services Inc.2$3,003
QOL Medical, LLC17$1,263
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC28$564
Neptune Medical Inc.1$450
Endogastric Solutions, Inc5$276
Regeneron Healthcare Solutions, Inc.5$220
Regeneron2$194
Ferring Pharmaceuticals Inc.11$185
Phathom Pharmaceuticals, Inc.3$161
Fujifilm Healthcare Americas Corporation1$149
Braintree Laboratories, Inc.9$145
Ardelyx, Inc.6$127
UCB, Inc.5$83
Mallinckrodt Hospital Products Inc.3$75
Sandoz3$64
Organon3$56
Aimmune Therapeutics, Inc.1$51
Daiichi Sankyo Inc.4$49
Lucid Diagnostics Inc.2$44
Ironwood Pharmaceuticals, Inc2$42
Shire North American Group Inc3$39
Intra-sana Laboratories1$34
Madrigal Pharmaceuticals1$26
Pharmacosmos Therapeutics Inc.1$26
Shionogi Inc1$18
Boehringer Ingelheim1$16
Alfasigma USA, Inc.1$16

How this compares

$3,678,312 in reported general payments places this provider in the 95th percentile of 103 gastroenterology providers in Nevada.

See all gastroenterology providers in Nevada →

Medicare billing

Part B allowed, 2024
$138,419
Medicare patients
470
Services billed
1,330

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Las Vegas

See the full list for Nevada →

Where these figures come from

Is this you, or does something look wrong? →